News | 22 January 2013
A study released last week reports that pharmaceutical companies are moving away from developing drugs for illnesses affecting the masses, and are concentrating on coming up with new treatments for rare disease sufferers. Nearly one in ten Americans ...
Click on the link to read the full article at MesotheliomaHelp.net (blog)
(This link will open in a new window)